The monitoring of physiological parameters is a crucial topic in promoting human health and an indispensable approach for assessing physiological status and diagnosing diseases. Particularly, it holds significant value for patients who require long-term…
Continue Reading
🚀 Dive into the latest innovations shaping the future of healthcare in our October Digital Health Digest. From AI’s expanding role in patient care to pioneering investments that could redefine health service delivery, we’re…
Continue Reading
South Korean health tech startup Sky Labs has raised 20.7 billion won ($15.3 million) in a Series C funding round led by the government-run Korea Development Bank. K2 Investment Partners, Devsisters Ventures, SJG Partners, and…
Continue Reading
South Korean health tech startup Sky Labs has raised 20.7 billion won ($15.3 million) in a Series C funding round led by the government-run Korea Development Bank. K2 Investment Partners, Devsisters Ventures, SJG Partners, and…
Continue Reading
Kentucky ranks fifth in the U.S. for adults with hypertension, many of whose condition is not controlled. Untreated high blood pressure increases the risk of heart attack, stroke and other serious health problems.THE PROBLEM
The…
This study aimed to elicit the preferences and willingness-to-pay for blood pressure (BP) telemonitoring programs. This study also investigated the different factors or participant characteristics that could influence preferences and choice behaviors. Participants with…
Continue Reading
By Mark Melchionna
June 30, 2023 – Among those with hypertensive disorders of pregnancy (HDP), a blood pressure (BP) home monitoring resource combined with the use of medication for BP titration helped with keeping patients out…
Continue Reading
Cardiovascular diseases (CVDs) are a leading cause of death worldwide. For early diagnosis, intervention and management of CVDs, it is highly desirable to frequently monitor blood pressure (BP), a vital sign closely related to…
Continue Reading
The following is a guest article by Steven LeBoeuf, Ph.D., Co-Founder & President at Valencell
Over the past decade, a motley bouquet of press releases [1, 2, 3], media reports [4, 5, 6], and peer-reviewed…
